![Frontiers | Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy Frontiers | Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy](https://www.frontiersin.org/files/Articles/568028/fmolb-07-00191-HTML/image_m/fmolb-07-00191-g001.jpg)
Frontiers | Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy
![TLR2 Agonistic Small Molecules: Detailed Structure–Activity Relationship, Applications, and Future Prospects | Journal of Medicinal Chemistry TLR2 Agonistic Small Molecules: Detailed Structure–Activity Relationship, Applications, and Future Prospects | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c01627/asset/images/large/jm0c01627_0006.jpeg)
TLR2 Agonistic Small Molecules: Detailed Structure–Activity Relationship, Applications, and Future Prospects | Journal of Medicinal Chemistry
TLR2 Agonistic Small Molecules: Detailed Structure–Activity Relationship, Applications, and Future Prospects | Journal of Medicinal Chemistry
![TLR2 Agonistic Small Molecules: Detailed Structure–Activity Relationship, Applications, and Future Prospects | Journal of Medicinal Chemistry TLR2 Agonistic Small Molecules: Detailed Structure–Activity Relationship, Applications, and Future Prospects | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c01627/asset/images/large/jm0c01627_0003.jpeg)